Thymosin Alpha-1 (TA1) – 10mg | Immunomodulatory Research Compound

Thymosin Alpha-1 | Immune Signaling Research Compound

Thymosin Alpha-1 is a synthetic 28-amino-acid compound corresponding to a naturally occurring thymic peptide originally isolated from thymosin fraction 5. It has been extensively studied in laboratory research involving innate and adaptive immune signaling, thymic pathways, and associated cellular mechanisms.

Key Research Areas:

• T-Cell Development & Signaling — Thymosin Alpha-1 is studied in relation to T-lymphocyte differentiation, maturation, and associated cellular signaling pathways.
• Innate Immune Signaling — Research has examined Thymosin Alpha-1 in relation to toll-like receptor (TLR) signaling, dendritic cells, and associated innate immune pathways.
• Cytokine Signaling Research — Laboratory studies investigate its relationship with cytokine production and immune-cell signaling mechanisms.
• Immune Pathway Research — Thymosin Alpha-1 is studied across experimental models involving cellular immune responses and associated molecular pathways.
• Comparative Immunology Research — Thymosin Alpha-1 provides a research model for investigating interactions among thymic compounds, immune cells, and related signaling systems.

Product Specifications:

• 28-amino-acid synthetic research compound
• 10mg lyophilized powder per vial
• ≥99% purity via HPLC and mass spectrometry, third-party COA available
• Store refrigerated (2–8°C) or frozen for long-term storage; protect from light and moisture

For laboratory and research use only. Not intended for human or animal consumption, administration, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic. Not FDA-approved for any indication in the United States.